Therefore, HSPB6 serves a critical function not only in regulating EMT but also in suppressing the PI3K/AKT/mTOR signaling pathway, further underscores its potential as a therapeutic target in the treatment of bladder cancer. Here, HSPB6 is linked to urinary bladder carcinoma.